A drug has received FDA approval for treatment, and a collaboration is providing drug monitoring services.
4 reports, 1 independent
Updated Jul 6
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A drug has received FDA approval for treatment, and a collaboration is providing drug monitoring services.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Celltrion
South Korean biopharmaceutical company
Nothing else this week.
-
PROMETHEUS
Belgian company
Nothing else this week.
Related events
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.
- InflaRx is seeking discussions with the FDA and collaborating with Staidson BioPharmaceuticals on clinical trials.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- ADC Therapeutics received accelerated approval for its drug from the FDA.